EP Patent

EP2399513A1 — System for non-invasive automated monitoring, detection, analysis, characterisation, prediction or prevention of seizures and movement disorder symptoms

Assigned to Qatar University Qstp-B · Expires 2011-12-28 · 14y expired

What this patent protects

A system adapted to monitor symptoms associated with movement disorders or seizures, which can then be used to predict, detect, analyse, characterise and or prevent or subdue said symptoms. The system comprises data acquisition means, recording means, and a signal processing unit…

USPTO Abstract

A system adapted to monitor symptoms associated with movement disorders or seizures, which can then be used to predict, detect, analyse, characterise and or prevent or subdue said symptoms. The system comprises data acquisition means, recording means, and a signal processing unit, which signal processing unit is adapted to filer and analyse user data to determine whether observed data is associated with a predetermined condition in real time. In the event that the data is associated with a predetermined condition, the processing unit sends a signal to an alert generation and propagation module which then alerts a monitoring unit. The system may be connected to an automated drug delivery system to allow delivery of an appropriate dose if a predetermined condition is detected or predicted.

Drugs covered by this patent

Patent Metadata

Patent number
EP2399513A1
Jurisdiction
EP
Classification
Expires
2011-12-28
Drug substance claim
No
Drug product claim
No
Assignee
Qatar University Qstp-B
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.